Making Moves in Multiple Myeloma in NYC

Published: Wednesday, Jan 23, 2019



We headed to New York City, New York, for a State of the Science Summit on Multiple Myeloma. At the meeting, we spoke with the faculty of Mount Sinai to get their take on stem cell transplant, minimal residual disease, maintenance options, and treatment approaches for newly diagnosed myeloma. They also discussed outcomes for relapsed/refractory disease, novel agents in development, chimeric antigen receptor T-cell therapy, and immunotherapy.
View Conference Coverage
Online CME Activities
$cme$
Publication Bottom Border
Border Publication
x